J1322 Medicaid reimbursement rate by state (2026)
Injection, elosulfase alfa, 1 mg. Medicaid pays a median of $319.51 for J1322 across 38 states, from $211.46 in New Jersey to $359.27 in Utah.
- States publishing
- 38
- National median
- $319.51units vary by state
- Lowest
- $211.46New Jersey
- Highest
- $359.27Utah
What does Medicaid pay for J1322?
38 state Medicaid programs publish a fee-for-service rate for J1322. The national median is $319.51 (units differ between states). Utah pays the most, $359.27, and New Jersey the least, $211.46, a 1.7x spread.
J1322 rate by state: highest, middle and lowest
One like-for-like fee-for-service rate per state, ranked. The workspace lists all 38 states with every variant, modifier and effective date.
How to read this table
- Order. States are listed from the highest published rate to the lowest. No single unit is shared by 8 or more states for J1322, so the order is by published amount and is not a like-for-like rank.
- Medicaid rate. The most the state's fee-for-service program pays for one unit, as published. 10 of the 38 states list more than one rate for J1322, by modifier, provider type or setting; the table shows the one that matches the provider level and setting used across states, without add-ons.
- Unit. Of the 38 states, 1 publish J1322 per unit and 1 per 1 mg, and 36 schedules print no unit at all (a flat amount per service).
- Per hour. J1322 is not billed in time units in these states, so no hourly figure is shown.
- Managed-care plans. The rule the state sets for its plans on this rate. What each rule means is explained below.
- % of Medicare. No Medicare physician fee schedule amount is on file for J1322, so there is no percentage.
- Source and date. Each Source link opens the state's own document; “since” is the date the rate took effect.
Why J1322 rates differ between states
Published rates for J1322 run from $211.46 in New Jersey to $359.27 in Utah, a 1.7x gap in the same unit. Half the states pay more than the median of $319.51 and half pay less. The usual reasons for a spread like this in pharmacy rates:
- States differ in whether they pay a fixed fee, a percentage of a benchmark or invoice cost.
- Drugs given in a practice or clinic are commonly priced from a benchmark such as average sales price or wholesale acquisition cost, which moves every quarter.
- For children, many vaccines are supplied through the federal Vaccines for Children program, so the Medicaid payment can be for administration only.
Timing matters too. 33 states set the current rate for J1322 in 2026 or later, while 2 states still pay a rate that took effect in 2022 or earlier. A state that has not updated its rate in years will drift down the ranking as others raise theirs.
What managed-care plans pay for J1322
Most Medicaid members are in managed-care plans, and plans don't publish their provider fee schedules. For J1322, the public signal is the rule each state sets for its plans, recorded on each rate above.
In 6 states, the published rate binds plans: a floor, a pass-through or a state-set rate. In 17 states, plans negotiate and the published rate is a benchmark or out-of-network default. In 1 state, the service is paid outside the plans or through a state-directed payment. The rule for the remaining 14 states is not classified yet.
- Plans negotiate; the published rate applies out of network (17 states). In-network rates can be above or below the published rate. The published rate is the benchmark both sides know, and the fallback if no contract is signed.
- Plans must pay at least the published rate (5 states). The published rate is your floor. Negotiate up from it, and if a plan pays less, the contract provision is the basis for a payment dispute.
- The state sets the plan rate (1 state). There is little to negotiate on price. Contracting is about network participation, authorization and billing terms.
- Paid by the state, outside the plans (1 state). Bill the state's Medicaid program, not the plan, at the published rate. There is no plan contract to negotiate for this service.
Plan-negotiated rates are never estimated here. To see the rule and its citation for a particular state, open that state's managed-care page, for example Utah managed care.
Units and billing for J1322
J1322 is a HCPCS Level II drug code in the pharmacy line, billed mostly by practices and clinics that administer vaccines and drugs. J codes cover drugs that are not self-administered. One unit is the dose stated in the code, so a claim for a larger dose bills several units.
Drug codes are billed in units of the dose stated in the code, so a larger dose bills more units. Many states require the National Drug Code (NDC) on the claim alongside the billing code.
Before billing, confirm the rate, unit and any modifier with the state's current schedule or the plan: the amounts here are as published, not a guarantee of payment.
Frequently asked questions
What does Medicaid pay for J1322?
It depends on the state. Of the 38 states with a published fee-for-service rate, the median is $319.51. Utah pays the most ($359.27) and New Jersey the least ($211.46).
Which state pays the highest Medicaid rate for J1322?
Utah, at $359.27, effective 2026-10-01.
Which state pays the lowest Medicaid rate for J1322?
New Jersey, at $211.46, effective 2025-01-01.
What unit is J1322 billed in?
Of the 38 states, 1 publish J1322 per unit and 1 per 1 mg, and 36 schedules print no unit at all (a flat amount per service).
Do managed-care plans pay the same rate for J1322?
Not necessarily. In 6 states, the published rate binds plans: a floor, a pass-through or a state-set rate. In 17 states, plans negotiate and the published rate is a benchmark or out-of-network default. In 1 state, the service is paid outside the plans or through a state-directed payment. The rule for the remaining 14 states is not classified yet. Each rule is cited to the plan contract, statute or notice in the workspace.